XML 46 R31.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Schedule of Stock Reserved for Future Issuance
As of March 31, 2022, the Company had reserved shares of common stock for future issuances under the 2018 Plan and 2021 Plan as follows (in thousands):
Blockcap Plans2018 Plan2021 Plan
Options outstanding
7,332 24,610 — 
Unvested restricted stock and restricted stock units outstanding
4,830 92,070 — 
Vested restricted stock and restricted stock units outstanding1,827 1,363 — 
Available for future stock option and restricted stock units and grants
— 13,970 45,000 
Total outstanding and reserved for future issuance
13,989 132,013 45,000 
Schedule of Share-based Compensation Arrangements by Share-based Payment Award Stock-based compensation expense for the three months ended March 31, 2022 and 2021 is included in the Company’s Consolidated Statements of Operations and Comprehensive (Loss) Income as follows:
Three Months Ended March 31,
20222021
Cost of revenue$2,039 $— 
Research and development1,882 — 
Sales and marketing458 — 
General and administrative21,418 588 
Total stock-based compensation expense$25,797 $588